23,714 Shares in Privia Health Group, Inc. (NASDAQ:PRVA) Bought by Proficio Capital Partners LLC

Proficio Capital Partners LLC acquired a new stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 23,714 shares of the company's stock, valued at approximately $464,000.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in PRVA. First Horizon Advisors Inc. lifted its holdings in Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock valued at $35,000 after acquiring an additional 632 shares during the period. Financial Management Professionals Inc. purchased a new stake in shares of Privia Health Group during the 4th quarter worth about $51,000. Quarry LP boosted its position in Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company's stock worth $60,000 after purchasing an additional 2,533 shares in the last quarter. Neo Ivy Capital Management purchased a new stake in Privia Health Group in the 3rd quarter worth $66,000. Finally, Nisa Investment Advisors LLC raised its position in Privia Health Group by 185.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 4,999 shares of the company's stock worth $98,000 after acquiring an additional 3,249 shares during the period. Institutional investors and hedge funds own 94.48% of the company's stock.

Analyst Upgrades and Downgrades

PRVA has been the subject of a number of research reports. Canaccord Genuity Group boosted their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "buy" rating in a research note on Friday, February 28th. JPMorgan Chase & Co. raised their target price on Privia Health Group from $27.00 to $28.00 and gave the company an "overweight" rating in a research report on Friday, November 29th. Stephens reaffirmed an "overweight" rating and issued a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. Macquarie began coverage on Privia Health Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $25.00 price objective for the company. Finally, Needham & Company LLC reaffirmed a "buy" rating and set a $30.00 target price on shares of Privia Health Group in a research note on Friday, March 21st. One research analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy" and a consensus price target of $26.67.

Remove Ads

Privia Health Group Price Performance

Shares of NASDAQ:PRVA traded down $0.33 during mid-day trading on Friday, reaching $22.59. 757,835 shares of the company were exchanged, compared to its average volume of 774,939. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $26.04. The firm's 50-day simple moving average is $23.79 and its 200 day simple moving average is $21.13. The firm has a market cap of $2.72 billion, a price-to-earnings ratio of 225.92, a P/E/G ratio of 3.47 and a beta of 0.85.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.